Аллергические болезни: диагностика и лечение - Паттерсон Р.
ISBN 5-9231-0011-8
Скачать (прямая ссылка):
24. American Academy of Allergy. Statement by executive committee 11 Ibid. - 1980. - Vol. 66. -P. 431.
25. Sundin B. et al. Immunotherapy with partially purified and standardized animal dander extracts.
1. Clinical results from double-blind study on patients with animal dander asthma // Ibid. - 1986. -Vol. 77. - P. 478.
26. Van Metre T.E.Jr. et al. Immunotherapy for cat asthma // Ibid. - 1988. - Vol. 82. - P. 1055.
27. Ohman JL et al. Immunotherapy in cat induced asthma: double blind trial with evaluation of both in vivo and in vitro responses. J Allergy Clin Immunol 1984,74:230
28. Adolphson C.R. et al. Standardization of allergens 11 Manual of Clinical Immunology / Eds. N.R. Rose, H. Friedman. - Washington: Am. Society for Microbiology, 1986. - P. 652.
29. Gleich G.J. et al. Measurement of the potency of allergy extracts by their inhibitory capacities in the radioallergosorbent test // J. Allergy Clin. Immunol. - 1974. - Vol. 53. - P. 158.
30. Baer H. et al. The potency and antigen E content of commercially prepared ragweed extracts // J. Allergy. - 1970. - Vol. 45. - P. 347.
31. Baer H. et al. The potency and group I antigen content of six commercially prepared grass pollen extracts // J. Allergy Clin. Immunol. - 1974. - Vol. 54. - P. 157.
32. BausquetJ. et al. Immunotherapy with a standardized Dematophagoides pteronyssinus extract // Ibid. - 1985. - Vol. 76. - P. 734.
33. Van Metre T.EJr. et al. Immunotherapy decreases skin sensitivity to cat extract // Ibid. - 1989. -Vol. 83. - P. 888.
34. Lowenstein H. Quantitative immunoelectrophoretic methods as a tool for the analysis and isolation of allergens // Prog. Allergy. - 1978. - Vol. 25. - P. 1.
35. Helm R.M. et al. Production and testing of an international reference standard of short ragweed pollen extract // J. Allergy Clin. Immunol. - 1984. - Vol. 73. - P. 790.
36. Ford A. et al. A collaborative study on the first international standard of Dermatophagoides pteronyssinus (house-dust mite) extract // Ibid. - 1985. - Vol. 75. - P. 676.
37. Hirsch S.R. et al. Rinkel injection therapy: a multicenter-controlled study // Ibid. - 1981. -Vol. 68. - P. 133.
38. Van Metre T.EJr. et al. A comparison of immunotherapy schedules for injection treatment of ragweed hay fever // Ibid. - 1982. - Vol. 69. - P. 181.
39. Fadal R.G., NalebujfDJ. A study of optimum dose immunotherapy in pharmacological treatment failures // Arch. Otolaryngol. - 1980. - Vol. 106. - P. 38.
40. Adkinson N.R Jr. The radioallergosorbent test: uses and abuses // J. Allergy Clin. Immunol. -1980.-Vol. 65.-P. 1.
41. Position Statement. The use of in vitro tests for IgE antibody in the specific diagnosis of IgE-mediated disorders and in the formulation of allergen immunotherapy // Ibid. - 1992. - Vol. 90. -P. 263.
42. Phanuphak P., Kohler P.F. Recent advances in allergic vasculitis // Adv. Allergy Pulmon. Dis. -1978.-Vol. 5.-P. 19.
43. Levinson Al. et al. Evaluation of the adverse effects of long term hyposensitization // J. Allergy Clin. Immunol. - 1978. - Vol. 62. - P. 109.
44. Metzger W.J. et al. The safety of immunotherapy during pregnancy 11 Ibid. - Vol. 61. - P. 268.
206
45. Physicians* Desk Reference. - 50th ed. -Oradell: Medical Economics Data, 1996.
46. American Academy of Allergy. Position statement: beta-adrenergic blockers, immunotherapy, and skin testing // J. Allei^y Clin. Immunol. - 1989. - Vol. 84. - P. 129.
47. Georgitis J.W. et al. Local nasal immunotherapy: efficacy of low-dose aqueous ragweed extract I I Ibid. - 1985. - Vol. 75. - P. 496.
48. TaudorfE. et al. Oral immunotherapy in birch pollen hay fever// Ibid. - 1987. - Vol. 80. - P. 153.
49. Scadding O.K., BrostoffJ. Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite // Clin. Allergy. - 1986. - Vol. 16. - P. 483.
50. Nelson H.S. et al. A double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized cat extract // J. Allergy Clin. Immunol. - 1993. - Vol. 92. - P. 229.
51. Roberts A.M. et al. Recombinant pollen allergens from Dactylis glomerata II Immunology. -1992.-Vol. 76.-P. 389.
52. Katz D.H. Lymphocyte Differentiation, Recognition and Regulation. - N.Y.: Academic Press,
1977.-648 p.
53. Sehon A.H., Lee W.Y. Suppression of immunoglobulin E antibodies with modified allergens 11 J. Allergy Clin. Immunol. - 1979. - Vol. 64. - P. 242.
54. Takatsu K. et al. Immunogenic properties of modified antigen E // J. Immunol. - 1975. - Vol. 115.-P. 1469.
55. Schad V.C. et al. The potential use of T-cell epitopes to alter the immune response // Semin. Immunol. - 1991. - Vol. 3. - P. 217.
56. O'Hehir R.E. et al. House dust mite allergy: from T-cell epitopes to immunotherapy // Eur. J. Clin. Invest. - 1993. - Vol. 23. - P. 763.
57. Patterson R., Harris K.E. Substance P and IgE-mediated allergy: reduction of rhesus IgE antibody after aerosol exposure to substance P and allergen // Allergy Proc. - 1993. - Vol. 14. - P. 53.
